Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,287 | N/A | N/A | -36,144 | -26,044 |
| Depreciation Amortization | 347 | N/A | N/A | 449 | 331 |
| Other Working Capital | 1,517 | N/A | N/A | 1,438 | -1,062 |
| Other Operating Activity | 23,820 | 0 | 0 | 5,023 | 2,142 |
| Operating Cash Flow | $-26,603 | $N/A | $N/A | $-29,234 | $-24,633 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -4,500 | -4,500 |
| PPE Investments | N/A | N/A | N/A | -116 | -116 |
| Purchase Of Investment | -95,761 | N/A | N/A | -183,765 | -120,813 |
| Sale Of Investment | 94,388 | N/A | N/A | 77,844 | 40,900 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -35 | -29 |
| Other Investing Activity | 0 | 0 | 0 | -35 | -29 |
| Investing Cash Flow | $-1,373 | $N/A | $N/A | $-110,572 | $-84,558 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,867 | N/A | N/A | 83,201 | 44,039 |
| Other Financing Activity | 118,248 | 0 | 0 | 394 | -219 |
| Financing Cash Flow | $153,115 | $N/A | $N/A | $83,595 | $43,820 |
| Exchange Rate Effect | 218 | N/A | N/A | -269 | 8 |
| Beginning Cash Position | 31,677 | N/A | N/A | 88,157 | 88,157 |
| End Cash Position | 157,034 | N/A | N/A | 31,677 | 22,794 |
| Net Cash Flow | $125,357 | $N/A | $N/A | $-56,480 | $-65,363 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,603 | N/A | N/A | -29,234 | -24,633 |
| Capital Expenditure | N/A | N/A | N/A | -116 | -116 |
| Free Cash Flow | -26,603 | 0 | 0 | -29,350 | -24,749 |